Thirty years of hemophilia treatment in the Netherlands, 1972-2001.

Abstract:

:Since the introduction of replacement therapy in the early 1960s by the infusion of plasma-derived factor VIII and IX preparations, important changes have occurred for hemophilia patients. We studied the medical and social developments over 30 years of hemophilia treatment. Since 1972, 5 cross-sectional national postal surveys among all hemophilia patients in the Netherlands were performed, the latest in 2001. The prestructured questionnaires included items on treatment, the presence of inhibitory antibodies against factor VIII or IX, the annual number of bleeding episodes, use of inpatient hospital care, and hepatitis C and HIV infections. Response rate in 2001 was 70%. Young patients (<16 years) with severe hemophilia showed the largest increase in use of prophylaxis, from 34% in 1972 to 86% in 2001. The occurrence of hemorrhages has gradually decreased. Hospital admissions decreased from 47% of all patients in 1972 to 18% in 2001. Our study shows that the treatment of patients with severe hemophilia in the Netherlands has focused on the use of prophylactic treatment, especially in children. This has resulted in a decrease in bleeding frequency and an improvement of the medical and social circumstances of patients.

journal_name

Blood

journal_title

Blood

authors

Plug I,van der Bom JG,Peters M,Mauser-Bunschoten EP,de Goede-Bolder A,Heijnen L,Smit C,Zwart-van Rijkom JE,Willemse J,Rosendaal FR

doi

10.1182/blood-2004-05-2008

subject

Has Abstract

pub_date

2004-12-01 00:00:00

pages

3494-500

issue

12

eissn

0006-4971

issn

1528-0020

pii

2004-05-2008

journal_volume

104

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Subunit structure of the erythropoietin receptor analyzed by 125I-Epo cross-linking in cells expressing wild-type or mutant receptors.

    abstract::To analyze the structure of the murine erythropoietin receptor (EpoR), wild-type or mutant EpoR cDNAs were expressed in cell lines, and the proteins that cross-linked with 125I-labeled erythropoietin (Epo) were analyzed by immunoprecipitation using an antibody against the intracellular region of the cloned EpoR. COS-7...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miura O,Ihle JN

    更新日期:1993-04-01 00:00:00

  • Influence of plasma immunoglobulin level on antibody synthesis.

    abstract::In previous experimental animal studies it has been demonstrated that antibody depletion is not followed by increased antibody synthesis. To assess whether these results are conferrable to antibody-depleted humans, we measured free light chains (flcs) as markers of current antibody synthesis in 8 patients treated with...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0128

    authors: Goldammer A,Derfler K,Herkner K,Bradwell AR,Hörl WH,Haas M

    更新日期:2002-07-01 00:00:00

  • Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.

    abstract::Infusions of large numbers (> 10(8)/kg) of donor leukocytes can induce remissions in patients with chronic myeloid leukemia (CML) who relapse after marrow transplantation. We wanted to determine if substantially lower numbers of donor leukocytes could induce remissions and, if so, whether this would reduce the 90% inc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mackinnon S,Papadopoulos EB,Carabasi MH,Reich L,Collins NH,Boulad F,Castro-Malaspina H,Childs BH,Gillio AP,Kernan NA

    更新日期:1995-08-15 00:00:00

  • Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.

    abstract::The possibility of primitive hematopoietic cell ex vivo expansion is of interest for both gene therapy and transplantation applications. The engraftment of autologous rhesus peripheral blood (PB) progenitors expanded 10 to 14 days were tracked in vivo using genetic marking. Stem cell factor (SCF)/granulocyte colony-st...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tisdale JF,Hanazono Y,Sellers SE,Agricola BA,Metzger ME,Donahue RE,Dunbar CE

    更新日期:1998-08-15 00:00:00

  • Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature.

    abstract::Human polymorphonuclear leukocytes adhesion to endothelial cells during the early stage of inflammation leads to cell surface externalization of Annexin A1 (AnxA1), an effector of endogenous anti-inflammation. The antiadhesive properties of AnxA1 become operative to finely tune polymorphonuclear leukocytes transmigrat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-270520

    authors: Pederzoli-Ribeil M,Maione F,Cooper D,Al-Kashi A,Dalli J,Perretti M,D'Acquisto F

    更新日期:2010-11-18 00:00:00

  • HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling.

    abstract::Human immunodeficiency virus type 1 (HIV-1) uses the chemokine receptors CCR5 and CXCR4 as coreceptors for entry. It was recently demonstrated that HIV-1 glycoprotein 120 (gp120) elevated calcium and activated several ionic signaling responses in primary human macrophages, which are important targets for HIV-1 in vivo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.10.2909

    authors: Del Corno M,Liu QH,Schols D,de Clercq E,Gessani S,Freedman BD,Collman RG

    更新日期:2001-11-15 00:00:00

  • Cervical carotid artery disease in sickle cell anemia: clinical and radiological features.

    abstract::Cervical internal carotid artery (cICA) occlusion is a recognized cause of acute ischemic stroke (AIS) in sickle cell disease (SCD), but the associated clinical and radiologic features are not well described. We reviewed data on cervical magnetic resonance angiography (cMRA) performed prospectively in 67 patients (55 ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2011-03-337915

    authors: Telfer PT,Evanson J,Butler P,Hemmaway C,Abdulla C,Gadong N,Whitmarsh S,Kaya B,Kirkham FJ

    更新日期:2011-12-01 00:00:00

  • Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis.

    abstract::Pacritinib (SB1518) is a Janus kinase 2 (JAK2), JAK2(V617F), and Fms-like tyrosine kinase 3 inhibitor that does not inhibit JAK1. It demonstrated a favorable safety profile with promising efficacy in phase 1 studies in patients with primary and secondary myelofibrosis (MF). This multicenter phase 2 study further chara...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2013-02-484832

    authors: Komrokji RS,Seymour JF,Roberts AW,Wadleigh M,To LB,Scherber R,Turba E,Dorr A,Zhu J,Wang L,Granston T,Campbell MS,Mesa RA

    更新日期:2015-04-23 00:00:00

  • Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis.

    abstract::Accumulating evidence has designated B cells as central players in the pathogenesis of immune diseases. In the late 1990s, anti-CD20 monoclonal antibodies were developed for the treatment of B-cell non-Hodgkin lymphomas, offering the opportunity to efficiently deplete the B-cell compartment for therapeutic immunointer...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-01-266668

    authors: Thaunat O,Morelon E,Defrance T

    更新日期:2010-07-29 00:00:00

  • Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia.

    abstract::Azacitidine treatment of myelodysplastic syndromes (MDSs) generally exacerbates thrombocytopenia during the first treatment cycles. A Study of Eltrombopag in Myelodysplastic Syndromes Receiving Azacitidine (SUPPORT), a phase 3, randomized, double-blind, placebo-controlled study, investigated the platelet supportive ef...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2018-06-855221

    authors: Dickinson M,Cherif H,Fenaux P,Mittelman M,Verma A,Portella MSO,Burgess P,Ramos PM,Choi J,Platzbecker U,SUPPORT study investigators.

    更新日期:2018-12-20 00:00:00

  • Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

    abstract::Hematide is an investigational pegylated synthetic peptide that stimulates erythropoiesis in animal models and is being developed for the treatment of anemia associated with chronic renal failure and cancer. This study evaluated the safety and pharmacodynamics of single, intravenous doses (0.025, 0.05, and 0.1 mg/kg) ...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2006-04-015818

    authors: Stead RB,Lambert J,Wessels D,Iwashita JS,Leuther KK,Woodburn KW,Schatz PJ,Okamoto DM,Naso R,Duliege AM

    更新日期:2006-09-15 00:00:00

  • Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate

    abstract::To determine the clonal nature of hematopoiesis and to assess lineage involvement in patients with myelodysplastic syndromes (MDS), we used restriction fragment length polymorphisms of the X-linked genes phosphoglycerate kinase (PGK1) and hypoxanthine phosphoribosyltransferase (HPRT) and the X-linked probe M27 beta. E...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Kamp H,Fibbe WE,Jansen RP,van der Keur M,de Graaff E,Willemze R,Landegent JE

    更新日期:1992-10-01 00:00:00

  • A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells.

    abstract::Various virus infections cause dysfunctional hemostasis and in some instances lead to the development of viral hemorrhagic fever syndrome. How do diverse viruses induce the expression of tissue factor on vascular cells? We hypothesize that a direct stimulation of pattern recognition receptors (PRR) by viral nucleic ac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-02-137901

    authors: Shibamiya A,Hersemeyer K,Schmidt Wöll T,Sedding D,Daniel JM,Bauer S,Koyama T,Preissner KT,Kanse SM

    更新日期:2009-01-15 00:00:00

  • Near-normal circulatory survival of rabbit red cells exposed to high levels of Ca and ionophore in vitro.

    abstract::The belief is widely held, on the basis of indirect evidence, that a substantial, even brief elevation of red cell Ca content must result in a marked shortening of circulatory survival. To test this notion directly, we exposed rabbit red cells in vitro to the ionophore A23187 and Ca so as to produce sustained uniform ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bookchin RM,Roth EF Jr,Lew VL

    更新日期:1985-07-01 00:00:00

  • Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge.

    abstract::Pharmacologic infusion of activated protein C (APC) improves survival in severe sepsis, and platelet factor 4 (PF4) accelerates APC generation in a primate thrombin-infusion model. We now tested whether endogenous platelet PF4 content affects APC generation. Mice completely deficient in PF4 (mPF4(-/-)) had impaired AP...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-081901

    authors: Kowalska MA,Mahmud SA,Lambert MP,Poncz M,Slungaard A

    更新日期:2007-09-15 00:00:00

  • Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl.

    abstract::Bcr-Abl tyrosine kinase activity initiates a number of intracellular signaling cascades that result in leukemogenesis. Imatinib mesylate, a specific Bcr-Abl tyrosine kinase inhibitor, has been highly successful in the treatment of chronic myelogenous leukemia (CML). However, the emergence of imatinib resistance and th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-3864

    authors: Gu JJ,Santiago L,Mitchell BS

    更新日期:2005-04-15 00:00:00

  • All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.

    abstract::We conducted a multicenter trial of treatment with all-trans retinoic acid (ATRA) for newly diagnosed acute promyelocytic leukemia (APL) in the AML-92 study and compared it with our previous study with standard intensive chemotherapy, the AML-89 study, in the view of complete remission (CR) rate, incidence of early de...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Kanamaru A,Takemoto Y,Tanimoto M,Murakami H,Asou N,Kobayashi T,Kuriyama K,Ohmoto E,Sakamaki H,Tsubaki K

    更新日期:1995-03-01 00:00:00

  • The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.

    abstract::Ecotropic viral integration site 1 (Evi1) is one of the master regulators in the development of acute myeloid leukemia (AML) and myelodysplastic syndrome. High expression of Evi1 is found in 10% of patients with AML and indicates a poor outcome. Several recent studies have indicated that Evi1 requires collaborative fa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-368654

    authors: Watanabe-Okochi N,Yoshimi A,Sato T,Ikeda T,Kumano K,Taoka K,Satoh Y,Shinohara A,Tsuruta T,Masuda A,Yokota H,Yatomi Y,Takahashi K,Kitaura J,Kitamura T,Kurokawa M

    更新日期:2013-05-16 00:00:00

  • Rapid prenatal diagnosis of beta thalassemia using DNA amplification and nonradioactive probes.

    abstract::We used in vitro DNA amplification by the polymerase chain reaction and nonradioactive probes for prenatal diagnosis of beta thalassemia in Chinese from the Guangdong province. Exact molecular diagnoses were made in all 20 fetuses studied over a 6-month period. We conclude that this method of prenatal diagnosis for be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cai SP,Chang CA,Zhang JZ,Saiki RK,Erlich HA,Kan YW

    更新日期:1989-02-01 00:00:00

  • Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

    abstract::During mouse cytomegalovirus (CMV) infection, a population of Ly49H(+) natural killer (NK) cells expands and is responsible for disease clearance through the induction of a "memory NK-cell response." Whether similar events occur in human CMV infection is unknown. In the present study, we characterized the kinetics of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-386995

    authors: Foley B,Cooley S,Verneris MR,Pitt M,Curtsinger J,Luo X,Lopez-Vergès S,Lanier LL,Weisdorf D,Miller JS

    更新日期:2012-03-15 00:00:00

  • Transforming growth factor-beta regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors.

    abstract::The cell-surface receptor c-kit and its cognate ligand stem-cell factor (SCF) or steel factor (SLF) are important for the maintenance of hematopoiesis both in vitro and in vivo. Transforming growth factor-beta (TGF-beta) has been shown to be a potent inhibitor of SLF-mediated synergistic growth of murine Lin-Sca-1+ pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dubois CM,Ruscetti FW,Stankova J,Keller JR

    更新日期:1994-06-01 00:00:00

  • Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease.

    abstract::Epstein-Barr virus (EBV)-driven posttransplantation lymphoproliferative disease (PTLD) is a serious complication of immunosuppression after either stem cell transplantation (SCT) or solid organ transplantation (SOT). Adoptive transfer of EBV-specific cytotoxic T lymphocytes (EBV-CTLs) is an effective prophylaxis and t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-07-228387

    authors: Brewin J,Mancao C,Straathof K,Karlsson H,Samarasinghe S,Amrolia PJ,Pule M

    更新日期:2009-11-26 00:00:00

  • Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies.

    abstract::Five novel monoclonal antibodies (mAbs; p0p 1-5) were used to characterize the structural and functional properties and the in vivo expression of the murine GPIb-IX complex (von Willebrand factor receptor). The molecular weights of the subunits are similar to the human homologs: GPIbalpha (150 kd), GPIbbeta (25 kd), a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bergmeier W,Rackebrandt K,Schröder W,Zirngibl H,Nieswandt B

    更新日期:2000-02-01 00:00:00

  • When a little aspirin may be enough.

    abstract::In this issue of Blood, Larocca et al in a large prospective study show that thromboprophylaxis with low-dose aspirin is very effective in previously untreated myeloma patients with a low thromboembolic risk receiving lenalidomide with low-dose dexamethasone. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2011-08-375089

    authors: Kastritis E,Dimopoulos MA

    更新日期:2012-01-26 00:00:00

  • Phenotype analysis of hematopoietic CD34+ cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction.

    abstract::A strategy to phenotype rare populations of hematopoietic cells expressing the cell-surface marker CD34 was studied. The antigenic phenotype of umbilical core blood (CB) CD34+ cells was investigated using flow cytometry and compared with the mRNA-phenotype determined by cDNA-polymerase chain reaction (cDNA-PCR) analys...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Thoma SJ,Lamping CP,Ziegler BL

    更新日期:1994-04-15 00:00:00

  • Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets.

    abstract::The balanced manifestation of effector functions and the generation of long-living memory cells is a hallmark of efficient CD8(+) T-cell response. Accumulating data pinpoint CD4(+) CD25(high) regulatory T (Treg) cells as a key factor for the inefficiency of CD8(+) T-cell responses in viral persistence. Little is known...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-151407

    authors: Nikolova M,Lelievre JD,Carriere M,Bensussan A,Lévy Y

    更新日期:2009-05-07 00:00:00

  • HTLV-III/LAV antibody status of spouses and household contacts assisting in home infusion of hemophilia patients.

    abstract::Thirty-four adult and pediatric hemophilia A and B patients and 50 nonhemophilic members belonging to 28 families were enrolled in August 1984 in a study of human T cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) antibody status and T cell subpopulation numbers. All 50 household contac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lawrence DN,Jason JM,Bouhasin JD,McDougal JS,Knutsen AP,Evatt BL,Joist JH

    更新日期:1985-09-01 00:00:00

  • Formation and functioning of the factor IXa-VIII complex on the surface of endothelial cells.

    abstract::The formation and functioning of the factor X activating complex on the surface of cultured human venous endothelial cells (HVEC) were investigated. To the HVEC monolayer human factors IXa, VIII, X, CaCl2, and S-2222 were added, and a gradually increasing activation of factor X was observed. The maximum activity of 88...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Váradi K,Elödi S

    更新日期:1987-02-01 00:00:00

  • Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.

    abstract::Hemophilic bleeding into joints causes synovial and microvascular proliferation and inflammation (hemophilic synovitis) that contribute to end-stage joint degeneration (hemophilic arthropathy), the major morbidity of hemophilia. New therapies are needed for joint deterioration that progresses despite standard intraven...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-131417

    authors: Sun J,Hakobyan N,Valentino LA,Feldman BL,Samulski RJ,Monahan PE

    更新日期:2008-12-01 00:00:00

  • Detection of the carrier state for classic hemophilia using an enzyme-linked immunosorbent assay (ELISA).

    abstract::A high proportion of carriers of classic hemophilia can be identified in the laboratory because, in comparison to normal women, the concentration of antigens related to antihemophilic factor (AHF, factor VIII) that are detected in their plasma by heterologous antiserum (factor VIIIR:Ag) is relatively higher than the t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fishman DJ,Jones PK,Menitove JE,Ratnoff OD,Everson B

    更新日期:1982-06-01 00:00:00